PM Modi to address rally in Himachal Pradesh today On the completion of one year of BJP government in HP

New Delhi, Dec. 26 -- On the completion of one year of BJP government in Himachal Pradesh, Prime Minister Narendra Modi will visit north Dharamashala Thursday. Prime Minister Modi will address Jan Aa... Read More

Lok Sabha to debate Triple Talaq Bill today

New Delhi, Dec. 26 -- Both the Houses of Parliament will resume Thursday after a weekend and a three-day break on account of Christmas. The Lok Sabha is set to debate on the Muslim Women (Protection o... Read More

Lok Sabha scheduled to take up Triple Talaq Bill Thursday

NEW DELHI, Dec. 26 -- The Lok Sabha is scheduled to take up the Muslim Women (Protection of Rights on Marriage) Bill, 2018 tomorrow. Law Minister Ravi Shankar Prasad will move the Bill to protect the... Read More

New beginning made with CSR in last 4 years: Jaitley

NEW DELHI, Dec. 26 -- UNION Finance Minister Arun Jaitley has said that a new beginning has been made in the past four years in India regarding Corporate Social Responsibility CSR. Addressing a funct... Read More

Chidambaram wants to know why GST goals are changing

New Delhi, Dec. 26 -- Former Finance Minister P. Chidambaram on Wednesday raised questions about what caused the change in the "declared goals" of the Goods and Services Tax (GST) regime, why it was b... Read More

BJP has a family problem and it's not Gandhi-Nehru

Srinagar, Dec. 26 -- The BJP has a crisis brewing at home. Its MPs, MLAs, leaders and workers are all getting disillusioned and carping. And so are many of its allies who once helped the party shed it... Read More

The case against surveillance

Srinagar, Dec. 26 -- Last week, a Ministry of Home Affairs (MHA) notification authorising 10 Central agencies to intercept, monitor, and decrypt online communications and data caused a furore in both ... Read More

Merck, Pfizer to terminate Phase III JAVELIN Ovarian 100 trial of avelumab

Singapore, Dec. 26 -- Merck and Pfizer Inc. has announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study of avelumab* did not support the study's initial hypothes... Read More

Rakuten Aspyrian closes $284 Million Series C Financing for late-stage oncology pipeline

Singapore, Dec. 26 -- Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform has announced that it has raised an ... Read More

Xynomic Pharma acquires global exclusive rights for Boehringer Ingelheim's cancer drug

Singapore, Dec. 26 -- Xynomic Pharmaceuticals, Inc., a clinical stage US-China oncology drug development company has announced that it has been granted an exclusive, worldwide license to develop, manu... Read More